ReSPECT-LM: Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases (clinicaltrials.gov) - Jun 14, 2022 - P1 | N=18 | Recruiting | Sponsor: Plus Therapeutics | Trial completion date: Dec 2022 ➔ Dec 2023 | Trial primary completion date: Jul 2022 ➔ Jul 2023
Trial completion date • Trial primary completion date • Oncology
|